NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED
IRVINE, CA, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the...
Stay updated with breaking news from Nucleus Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IRVINE, CA, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the...
IRVINE, CA, Feb. 11, 2022 -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. today announced the continued enrollment of its first in kind human clinical trial of its proprietary... | February 11, 2022
(Bloomberg) — Blackstone Inc. has amassed $11 billion to buy companies in Asia after raising its second private-equity fund for the region, nearly tripling its…
Quadrant Private Equity is the latest to join the dealmaking frenzy for clinical trials outfits.
Global investment manager Blackstone has agreed terms to acquire clinical trials provider Nucleus Network from Australian private equity firm Crescent Capital.